PDUFA VII Talks To Begin With COVID-19, Other Familiar Issues To Consider

 
• By Derrick Gingery

US FDA staffing problems and patient engagement enhancements will be listed as priorities during reauthorization kick-off meeting.

Building icon with inscription FDA and flag of The United States over abstract background. - Illustration
Real-world evidence and complex clinical trial issues also likely will emerge during the public meeting as PDUFA VII negotiation topics. • Source: Shutterstock

More from User Fees

More from Pathways & Standards